Products Low - Phos Calcium Acetate Tablets

Low - Phos Calcium Acetate Tablets

ATLANTIC manufactures Calcium Acetate Tablets which are prescribed for hyperphosphatemia for the final stage Renal Failure patient.

  • Low-Phos (Calcium Acetate), for individualized phosphate binding treatment, is simply easier for patients to swallow. Patients experience no Constipation, and very low incidence of bloating or gas common to calcium carbonate
  • Low-Phos is less often associated with hypercalcemia and presents no threat of aluminium toxicity and is not known to worsen hypochlorhydria

Compositions Available

  • Each uncoated tablet contains
  • Calcium Acetate USP - 667 mg

Packaging

A pack of bottle contains 75 tablets.

Download

Catalogue of Low Phos Tablets
 
Serve over 50,000 patients per year
Assist in over 5 Million dialysis treatments per year